The presence and clinical implications of α-2,6-galactose-linked sialic acids in non-small-cell lung cancer brain metastases - Preliminary study

Folia Histochemica et Cytobiologica

Volumn 52, Issue 2, 2014, Pages 104-111

  Pelak, Maciej J ^a   Jarosz, Bozena ^b   Straczynska Niemiec, Anita ^a   Krawczyk, Pawel ^b   Skoczylas, Piotr ^b   Pecka, Katarzyna M ^c   Snietura, Miroslaw ^a   Szumilo, Justyna ^b   Trojanowski, Tomasz ^b  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c Department of Surgery St Elisabeth Hospital   (Poland)

Author keywords

Alpha 2,6 sialic acids; Blood brain barrier; Brain metastases; CAMs; NSCLC; Survival

Indexed keywords

ALPHA 2,6 GALACTOSE SIALIC ACID; SIALIC ACID; UNCLASSIFIED DRUG; BETA-D-GALACTOSIDE ALPHA 2-6-SIALYLTRANSFERASE; GALACTOSE; N ACETYLNEURAMINIC ACID; SIALYLTRANSFERASE; TUMOR MARKER;

ADULT; ARTICLE; BRAIN METASTASIS; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; OVERALL SURVIVAL; PRIMARY TUMOR; SURVIVAL RATE; SURVIVAL TIME; ANALOGS AND DERIVATIVES; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CASE CONTROL STUDY; GENETICS; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; PATHOLOGY; SECONDARY;

BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; FEMALE; GALACTOSE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; N-ACETYLNEURAMINIC ACID; SIALYLTRANSFERASES; TUMOR MARKERS, BIOLOGICAL;

EID: 84904116471     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2014.0012     Document Type: Article

References (26)

1. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. Available from URL: http: //globocan.iarc.fr. Viewed: 10th Jan 2014.
2. Komaki R, Scott CB, Byhardt R et al. Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 1998; 42: 263-267.
3. Yaeger KA, Nair MN. Surgery for brain metastases. Surg Neurol Int. 2013; 4: 203.
4. Milas I, Komaki R, Hachiya T et al. Epidermal growth factor receptor, cyclooxygenase-2, and bax expression in the primary non-small cell lung cancer and brain metastases. Clin Cancer Res. 2003; 9: 1070-1076.
5. D'Amico T, Aloia T, Moore M-B et al. Predicting the sites of metastases from lung cancer using molecular biologic markers. Ann Thorac Surg. 2001; 72: 1144-1148.
6. Arnold S, Young A, Munn R et al. Expression of p53, bcl-2, e-cadherin, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasis. Clin Cancer Res. 1999; 5: 4028-4033.
7. Taatjes DJ, Roth J. Alteration in sialyltransferases and sialic acid expression accompanies cell differentiation in rat intestine. Eur J Cell Biol. 1988; 46: 289-298.
8. Hakomori SI. Bifunctional role of glycolipids. Modulators for transmembrane signalling and mediators for cellular interactions. J Biol Chem. 1990; 265: 18 713-18 716.
9. Powell LD, Whiteheart SW, Hart GW. Cell surface sialic acid influences tumor cell recognition in the mixed lymphocyte reaction. J Immunol. 1987; 139: 262-270.
10. Wang PH. Altered glycosylation in cancer: Sialic acids and sialyltransferases. J Cancer Molec. 2005; 1: 73-81.
11. Lise M, Belluco C, Perera SP, Patel R, Thomas P, Ganguly A. Clinical correlations of alpha-2, 6-sialyltransferase expression in colorectal cancer patients. Hybridoma. 2000; 19: 281-286.
12. Perez-Garay M, Arteta B, Pages L et al. a2, 3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo. PLoS One. 2010; 5: e12524. doi: 10.1371/jounal.pone.0012524.
13. De Bos P, Zhang X, Nadal C et al. Genes that mediate breast cancer metastasis to the brain. Nature. 2009; 459: 1005-1009.
14. Chiang CH, Wang CH, Chang HC, More S, Li WS, Hung WC. A novel sialyltransferase inhibitor AL10 suppresses invasion and metastasis of lung cancer cells by inhibiting integrin-mediated signaling. J Cell Physiol. 2010; 223: 492--499.
15. Varki A, Cummings RD, Esko JD et al. Essentials of Glycobiology (2nd edition). Cold Spring Harbor (NY); Cold Spring Harbor Laboratory Press 2009.
16. Kaneko Y, Hirotaka Y, Colley KJ, Moskal J. Expression of Galb1, 4GlcNAc a-2, 6-sialyltransferase and a-2, 6-linked sialoglycoconjugates in normal human and rat tissues. J Histochem Cytochem. 1995; 43: 945-954.
17. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999; 17: 1474-1481.
18. Kennecke H, Yerushalmi R, Woods R et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010; 28: 3271--3277.
19. Kaneko Y, Yamamoto H, Kersey DS, Colley KJ, Leestma JE, Moskal JR. The expression of Gal beta 1, 4GlcNAc alpha 2, 6 sialyltransferase and alpha 2, 6-linked sialoglycoconjugates in human brain tumors. Acta Neuropathol. 1996; 91: 284-292.
20. Barnes YC, Skelton TP, Stamenkovic I, Sgroi D. Sialylation of the sialic acid binding lectin sialoadhesin regulates its ability to mediate cell adhesion. Blood. 1999; 93: 1245-1252.
21. Poon T, Chiu C, Lai P et al. Correlation and prognostic significance of beta-galactoside alpha-2, 6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma. World J Gastroenterol. 2005; 11: 6701-6706.
22. Lin S, Kemmner W, Grigull S, Schlag PM. Cell surface alpha2, 6-sialylation affects adhesion of breast carcinoma cells. Exp Cell Res. 2002; 276: 101-110.
23. Matsushita Y, Hoff SD, Nudelman ED. Metastatic behavior and cell surface properties of HT-29 human colon carcinoma variant cells selected for their differential expression of sialyl-dimeric Le(x)-antigen. Clin Exp Metastasis. 1991; 9: 283--299.
24. Yu S, Fan J, Liu L, Zhang L, Wang S, Zhang J. Caveolin-1 up-regulates integrin a2, 6-sialylation to promote integrin a5b1-dependent hepatocarcinoma cell adhesion. FEBS Lett. 2013; 587: 782-787.
25. Dennis J, Waller C, Timpl R, Schirrmacher V. Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin. Nature. 1982; 300: 274-276.
26. Kroes RA, He H, Emmett MR et al. Overexpression of ST6GalNAcV, a ganglioside-specific alpha-2, 6-sialyltransferase, inhibits glioma growth in vivo. Proc Natl Acad Sci USA. 2010; 107: 12 646-12 651.